20
Participants
Start Date
November 20, 2024
Primary Completion Date
December 1, 2029
Study Completion Date
December 31, 2030
Various labs and imaging tests
Dexamethasone Suppression Test, Adrenocorticotropic Hormone (ACTH), Salivary Cortisol Levels, Vasopressin Stimulation test, Fasting Glucose, Fasting Insulin, Complete Metabolic Panel (CMP), Gamma-glutamyl transferase (GGT), Sex Hormone Binding Globulin, Cat scan of abdomen/Pelvis, Whole body dual energy x-ray absorptiometry (DXA) scan, Ultrasound Fibroscan Transient Elastography
RECRUITING
The Cleveland Clinic Foundation, Cleveland
Recordati Rare Diseases
INDUSTRY
The Cleveland Clinic
OTHER